
ãã£ãŒã«ãºã»ãªãŒããŒã®æ³çéé¿è¡ãšå¿ã®èªç±
TOPICS:äžåœå«ç人暩ããªã¢ã ã»ããã€ã³ãã€ã³ãã³ã³ãããŒã«ãããã¯ãããžãŒãã¥ãŒã©ã«ãªã³ã¯ç§åŠãã©ã³ã¹ãã¥ãŒãããºã
ACTIVISTÂ POSTÂ
2022幎4æ8æ¥
ããªã¢ã ã»ããã€ã³
å èšäºã¯ãã¡ãã
æ±ãæãå¿ã®èªç±ã«è§Šããããšèœãã - ãžã§ã³ã»ãã«ãã³ïŒ1608-1674幎ïŒ
ãŠã¯ã©ã€ããšãã·ã¢ã«æ³šç®ãéãŸãäžãç§ãããããã¯çããšåŒã¶ãã£ãŒã«ãºã»ãªãŒããŒãåå¯©ãæ±ããŠããããã£ãŒãªãŒã¯åœåãäžåœå ±ç£å ïŒCCPïŒã®ã¹ãã€ãšããŠèšŽããããããæçµçã«è£å€æã¯ãããŒããŒã倧åŠååŠã»ååŠçç©åŠéšã®å åŠéšé·ãè±çšã«é¢ãã6ã€ã®èšŽå ã§æçœªã«ãªã£ãã ãã ãšå€æããã®ã§ããã
ããªãŒããŒææã¯ã¹ãã€ã§ã¯ãªãããšãMukasey Frenchman LLPã®åŒè·å£«ã¯å®£èšããŠãããããªãŒããŒææã¯ã¹ãã€ã§ã¯ãªããäžåœã§äžæ³ãªä»äºãããŠãããªãã圌ã¯èµ·èšŽãããã¹ãã§ã¯ãªãã£ããããŒããŒã倧åŠãNIHãåœé²ç·çã¯ããªãŒããŒææã®ç§åŠç ç©¶ããå©çãåŸãŠãããã
å®éãåœé²ç·çã®åœé²é«çç ç©¶èšç»å±ïŒDARPAïŒãå«ãå€ãã®æ©é¢ãããªãŒããŒã®çºæåããå©çãåŸãŠããã
äžåœæ§æ³ã倧倱æ ïŒ
ãã©ã³ã¹äººåŒè·å£«ã¯ããªãŒããŒæ°ã¯ãæ¬ é¥ã®ããã€ãã·ã¢ããã®ç ç²è ãã§ãããããã®äžå ¬å¹³ã¯èš±ãããªãããšä»ãå ãããèšåããã®ã¯ãäžåœæ¿åºã«ããç±³åœã®æ©å¯ãæè¡ãæå 端ç ç©¶ãçããã£ã³ããŒã³ãšåœå±ãè©ãããã®ã«å¯Ÿæãããããåžæ³çïŒDOJïŒããã©ã³ãæ¿æš©äžã®2018幎ã«éå§ããããã£ã€ãã»ã€ãã·ã¢ãããã§ããããã¯ã€ãããŠã¹ã®è²¿æã»è£œé æ¿ç宀ã "äžåœã®çµæžç䟵ç¥ãç±³åœãšäžçã®æè¡ãšç¥ç財ç£ãããã«è ããã "ãšé¡ããå ±åæžãçºè¡šããã®ã¯2018幎6æã®ããšã§ãã£ãã
圌ãã¯ã"åžæ³çãèµ·ãããçµæžã¹ãã€ã®èµ·èšŽã®çŽ80ïŒ ãäžåœåœå®¶ã®å©çã«ãªãè¡çºã䞻匵ããäŒæ¥ç§å¯ã®çé£äºä»¶ã®çŽ60ïŒ ã«å°ãªããšãäžåœãšã®äœããã®é¢é£æ§ããã "ããšãçºèŠããŸããã
FBIé·å®ã¯ãªã¹ããã¡ãŒã»ã¬ã€ã§ããã"æãåœã®æ å ±ãšç¥ç財ç£ããããŠçµæžç掻åã«å¯Ÿããé·æçãªæå€§ã®è åšã¯ãäžåœããã®é²è«ãšçµæžã¹ãã€ã®è åšã§ãã "ãšè¿°ã¹ãŠããã®ã§ãã
ãªãŒããŒãšåœŒã®åŒè·å£«ã¯ããã©ã³ãå倧統é ãšã€ãã·ã¢ããã®ç®æšã誹è¬äžå·ããŠããŸãã"ãã®èšŽè¿œã¯åæ¿æš©ã宿œããæ¿æ²»æ¿çããçãŸãããã®ã§ããããäžåœæ§æ³ãã¯...ä»ã巚倧ãªå€±çãšããŠæ®éçã«èªèãããŠããŸãã"
倧倱æ ïŒ
ã¡ãªã¿ã«ããã®3æã«ã¯ãäžåœæ¿åºè·å¡ã®ç±³åœãã¶ãäžæ£ã«ååŸããé°è¬ã«å æ ãããã¥ãŒãžã£ãŒãžãŒå·ã®ç·ãæçœªå€æ±ºãåããã°ããã§ããã圌ã¯ãŸããç±³åœã®ç§åŠè ãåŠè ããšã³ãžãã¢ããã®ä»ã®å°éå®¶ãäžåœã§åãããããå§èªããããšã«ãé¢äžããŠããã
èŠèŠãã¯ãããŸãããïŒ
ã¢ã¡ãªã«ã§ç ç©¶éçºã«æºãã人ãã絊æãç ç©¶è²»ãå®éšã¹ããŒã¹ãªã©ã®ã€ã³ã»ã³ãã£ããšåŒãæãã«ãããã§åŸãç¥èãç ç©¶ãäžåœã«äŒãããšããããã°ã©ã ã§ãããå人èšç»ãã«ã確ãã«äžåœãšä»äºãããŠãããªãŒããŒã2008幎ããé¢ãã£ãŠããããããŠäžåœã¯ãäžåœã«å ¥æããã¢ã¡ãªã«ã®ç ç©¶ãšå°éç¥èããèªåœã®çµæžçã»è»äºçå©çã®ããã«å©çšããã®ã§ãã
ãªãŒããŒæ°ã®åŒè·å£«ã¯ããªãŒããŒæ°ã«å¯Ÿããçµæžçãç¥ç財ç£çã¹ãã€è¡çºã婿éè©æ¬ºã®èšŒæ ããŸã£ãããªãã«ããããããããã®ã倧èŠåŸãåãæ¿çãã®çµæãšããŠæšçã«ãã鮿ããããšäž»åŒµããŠããŸãã
ããã®ä»£ããã«ããã®èª€ã£ãæ¿çã¯ããªãŒããŒææã®ãããªåŠè¡ç ç©¶è ããäžåœã®äººæããã°ã©ã ãšã®åæ³çãªã³ãã¥ãã±ãŒã·ã§ã³ãäžåœã®åŠè¡æ©é¢ãšã®åæ³çãªå ±åç ç©¶ãé瀺ããªãã£ãããšãæšçã«ããŸããããšã圌ã®åŒè·å£«ã¯ä»ãå ããŸããã
ãããã¯çã¯2022幎3æã«å€æ±ºãåããäºå®ã§ãããã圌ã®åŒè·å£«ã¯è£å€ã®æ¥çšãå»¶æãã"å®¶æã®åé¡ã«é¢é£ããŠ2022幎3æ24æ¥ã«ä»¥åäºå®ãããŠããåœå€ãžã®åºåŒµãèæ ®ããåŒè·äººãååãªæºåæéã確ä¿ã§ããããã2022幎3æ31æ¥ã®æ°ããå¯©çæ¥ãèŠæ±ããŸãã "ãšè¿°ã¹ãŸããã
ã¡ãªã¿ã«ã91æ³ã®Rya W. Zobelå€äºãå®¶æã®åé¡ã«å¯ŸåŠããããã«ãªãŒããŒã®ããŠã³ã¿ã€ã ãèªããã®ã¯ããã2åç®ã§ãã1床ç®ã¯ãå·å šäœãå°éãããã«ããããããããªãŒããŒããã¹ãã³ãé¢ããããšãèš±å¯ããã
ãããç§ãã¡ãçããã®ãããªç¹æš©ãåŸãããšãã§ããã°ããã®ã ãã
ãªãŒããŒææã®ãåé ã®èŠæžããæåºãããçŽåŸã®ä»å¹Žããã€ãã³åžæ³çã¯Â "æ£ããã¢ãããŒã "ãäœçŸããŠããªããšããŠããã©ã³ãã»äžåœæ§æ³å šäœãå šé¢çã«ç Žæ£ããŠããŸã£ãã
åžæ³çã®ããŒã ããŒãžã§ãäžåœã€ãã·ã¢ãã£ããã®èšè¿°ãæ¢ããšã404ã§è¡šç€ºããããä¿¡ããããªããæ¿åºã¯ãMinistry of Truthã®ããã«ããŒãžãåé€ããŠããŸã£ãã®ã ã以åã¯ããã«æžããŠãã£ãã®ã ãã

çŸæç¹ã§ã¯ããŸãŒãã«å€äºã¯äºæ ãé芳ããŠããããéåžžã«é²è¡ãããªã³ãè «ããšå ±åãããŠãããªãŒããŒããèªç±äººãšããŠæ©ããããã«ãªããã©ããã¯ãæéã解決ããŠãããã ããã
è³ãžã®ã€ã³ãã©ã³ããç¿ãã人ãž
ãã£ãŒã«ãºã»ãªãŒããŒã¯ããµã€ããŒã°å¿èçµç¹ããåœé²ç·çãè³éæäŸããããã¹ã±ãŒã«ã®æ³šå°çšã¯ã€ã€ãŒããã³/ãŸãã¯æ³šå°çšããã€ã¹ãå«ã66以äžã®ãããã¯é¢é£ç¹èš±ã®éŠè¬è ã§ã身äœã5GãIoTïŒã¢ãã®ã€ã³ã¿ãŒãããïŒã«æ¥ç¶ããããšãã§ããããã«ãªããã€ãŒãã³ã»ãã¹ã¯ã®Neuralink/Neurolaceãžã®éãéããã®ãããªãŒããŒã®è³ã€ã³ãã©ã³ãã®ãããã¯ãããžãŒã§ãã
æšå¹Ž2021幎4æããã¥ãŒã©ãªã³ã¯ã¯9æ³ã®ãµã«ãããŒãžã£ãŒã®è³ã«ããããåã蟌ã¿ã"æãåããããšãèããã ã "ã§ãããªã²ãŒã ãPongããæåãããããã®è£ 眮ã¯ããµã«ãã³ã³ãã¥ãŒã¿ãšãããšãããŠããéã®ãã¥ãŒãã³æŽ»åãèšé²ãããã®ããŒã¿ãããã³ãŒãã»ã¢ã«ãŽãªãºã ãã«éã蟌ã¿ãããŒãžã£ãŒã®æã®åãããªã¢ã«ã¿ã€ã ã§äºæž¬ããããããŠããµã«ã¯ãžã§ã€ã¹ãã£ãã¯ã«è§Šããããšãªããã«ãŒãœã«ãæãéãã®å Žæã«ç§»åãããããšãã§ããããã«ãªã£ãã
"ãµã«ãè³å ãããã䜿ã£ãŠãæåéããã¬ãã·ãŒã§ãããªã²ãŒã ããã¬ã€ããŠããã®ã ïŒ" ãšããã¹ã¯ã¯è奮æ°å³ã«ã€ã¶ãããã
ãã¹ã¯ã«ããã°ããã®å®éšã¯ã人éã®æèãšäººå·¥ç¥èœã®èåãç®æããã¥ãŒã©ãªã³ã¯ç€Ÿã®éèŠãªã¹ãããã«ãªã£ããšãããTwitterã®æ ªåŒã9.2ïŒ ååŸããã°ããã®ãã¹ã¯æ°ã¯ã2幎åãã人äœå®éšã«ã€ããŠè©±ããŠããã圌ã®ç£èŠäžã§å°ãªããšã15å¹ã®ãã«ã¯éé·é¡ãæ»äº¡ããŠããã«ããããããããããç¶ããŠããã®ã ãç§ã¯ãããããã¹ã¯ã®ç¿ã®å€§è殺ããšåŒãã§ããŸãã
"...人éã«ããã€ã¹ãæèŒããã°ã鲿©ã¯å éããïŒç¿ãšãã¥ã¢ã³ã¹ã®ç°ãªãäŒè©±ãããã®ã¯é£ããïŒ"ãšããã¹ã¯ã¯èªã£ãã圌ã¯ã人é以å€ãå·»ã蟌ãã ã¹ã±ãŒã«ã¢ããã®æ¹æ³ãŸã§æ³å®ããŠããã
"ãããç¥çµå€ç§å»ãè¡ãã®ã§ããã°ã倧å¢ã®äººã«ã¹ã±ãŒã«ã¢ããã§ããããããªã "ãšããã¹ã¯ã¯ã€ã³ã¿ãã¥ãŒã§èªã£ãŠããã圌ã¯ããã®ç¹çްãªåŽåã人工ç¥èœãæã€ããããã«å§èšããã€ããã ããããã³ãŒãŒã®èª¿æ»ã§ã¯ã2030幎ãŸã§ã«8å人ã®äººéã®ä»äºãããããã«çœ®ãæãããšäºæž¬ããŠããã
2020幎2æããã¹ã¯ã¯TwitterãéããŠãNeuralinkã¯Â "æ©ããã°ä»å¹Žäžã«äººéã§å®éšã§ãã "ãšãã¡ã³ã«äŒããŠãããæè¿ããã¹ã¯ã¯ããã¥ãŒã©ãªã³ã¯ã2022幎ã«äººéã§è³å ãããã®å®éšãå§ããããšãç®æããŠãããšè¿°ã¹ãã

ãã¹ã¯ã«ããã°ããã®ããã»ã¹ã¯å€§ããããšã¯ãªããé è骚ã«å°ããªç©ŽãéããŠã¯ã€ã€ã¬ã¹ããããæ¿å ¥ããè³çµç¹ãéããŠçްãæè»ãªã糞ãã®ãããªé»æ¥µãæ¿å ¥ããã ãã ããã¹ã¯æ°ã¯ãå®éã®æ¡çšã«ã¯æè¡çã«FDAã®æ¿èªããã®ä»ã®èŠå¶ã®å¯©æ»ãå¿ èŠã ãšããŠããããã¡ããã ããã¹ã¯ã¯ãããã€ã¹ãåã蟌ãããã®åºæºãFDAãèŠæ±ãããã®ããé«ãã®ã§ãèŠå¶æ©é¢ã圌ã®Neuralinkãæ¿èªããããšã確信ããŠãããšè¿°ã¹ãŠããŸãã
ãããªãã§ããïŒ
ãã©ã³ã¹ãã¥ãŒããã¹ãã¯ãç¥çµæ©èœãè¡°ããç æ°ã修埩ããããã«ã人äœå®éšãããããšèšãã ããã"ãã¬ã€ã³ã»ã³ã³ãã¥ãŒã¿ãŒã»ã€ã³ã¿ãŒãã§ã€ã¹ã¯ãæªæãç æ°ã«ãã麻çºãæ±ãã人ã ã®åããå埩ããããã«éçºãããŠããŸãã"
ãããã圌ãã®çã®ç®çã¯ãããªããã¢ãã®ã€ã³ã¿ãŒãããããããªãã®åšãã®ãããããã¹ããŒãããªæ©æ¢°ã«æ¥ç¶ããæ¹æ³ãèŠã€ãåºãããšã ãšäž»åŒµãã人ãå€ãã§ããããããã²ãšã€ã®ç®æšã¯ã人ã®å¿ãèªã¿ãç®èã®äžã§ç£èŠã§ããããã«ããããšã§ãã
ããããæ¢åã®ç¥çµçްèéã®ä¿¡å·ãæ©æž¡ãããããšã¯ãè€éãªããšã§ãããã¹ã¯ãèšãããã«ãé«åž¯åå¹ ãšé«ç²ŸåºŠã®ç¥çµã€ã³ã¿ãŒãã§ãŒã¹ããããã倧ããªã€ã³ãã¯ãã¯ãååã«è©äŸ¡ãããŠããªãã®ã ã
ãã¹ã¯ã¯Twitterã§ãNeuralinkããã€ã¹ãè³åäžã«ããèšæ¶åªå€±ãåŠæ³ã®å埩ã«ã©ã®ããã«åœ¹ç«ã€ããšãã質åã«å¯ŸããŠããæ¬ é¥ã®ãã/æ¬ èœãããã¥ãŒãã³ãåè·¯ã§çœ®ãæããã®ã¯æ£ããèãæ¹ã ããšæžããŠããŸãã
圌ã¯ããã¥ãŒã©ãªã³ã¯ã®çºæã¯ãä»ã®è³ã€ã³ãã©ã³ããããåªããŠããå¿ èŠããããšæèšããŠãããããã¯ãåœŒãæ©æ¢°ãšäººéãèåãããå¥ã®æ§æ³ãæã£ãŠãããããªã®ã ãããã ãã©ã³ã¹ãã¥ãŒããã¹ãã®ç©¶æ¥µã®ç®æšã¯ã人éã®æèãããŠã³ããŒãã§ããç¡æ©ã»ææ©ãã¥ãŒããã€ãã®ãã©ãããã©ãŒã ãäœãããšã§ãããçµå±ã®ãšãããèäœã®å¯¿åœã¯éãããŠããã®ã ã
ãã®å Žåããã¹ã¯ã¯ããŠã¿ã»ã¢ã¬ã€ãã®ããšãæããŠããã圌ã«ããã°ã"æ·±å»ãªæ¬ ç¹ãããã«ãããããã "ãã§ã«äžéšã®äººéã®äžã«å ¥ã£ãŠããã®ã ãšããããŠã¿ã»ã¢ã¬ã€ã¯ãéçšè³ç£10å åè¶ ã®ãã©ãã¯ããã¯ãããããããã®ã ãCEOã®ã©ãªãŒã»ãã£ã³ã¯ã¯ãäžççµæžãã©ãŒã©ã ã®åœ¹å¡ãåããŠããããŠã¿ã»ã¢ã¬ã€ã®ãããã¯ã"ãã¬ã€ã³ã»ã³ã³ãã¥ãŒã¿ãŒã»ã€ã³ã¿ãŒãã§ãŒã¹ã®ããã®äººéã®ç®è³ªÂ "ã«é¢äžããŠããŸãã

"ãããäžäžã®æ·ååšå ·ã®ããã ããããã§ãçŸåšå€ãã®äººäœç ç©¶ã§äœ¿ãããŠãããã ïŒãã£ãšè¯ããªãã®ã¯é£ãããªãããšããã¹ã¯ã¯äžã®ç»åã«å¯ŸããŠTwitterã§è¿°ã¹ãŠããã
ãã©ã³ã¹ãã¥ãŒãããºã ã®çš®é¡ã®è³ããã
äžæ¹ããªã©ã³ããšEUã®æ¿åºã¯ããŠã¿ã»ã¢ã¬ã€ããã¹ãããæåã®ãã€ãããã»ã¹ã¿ãã£ã«è³éãæäŸããããã®è©Šéšã«ã¯3人ã®è¢«éšè
ãåå ããããã¯ã€ã³æ£è
ïŒç®èŠããŠããŠæèã¯ããããéžæçè±åç¶æ
ã«ããæ£è
ãã€ãŸãèšèªãæè¶³ãé¡ã®åããäœãåºãææ®µããªãïŒãè³ã€ã³ãã©ã³ãã§ã³ãã¥ãã±ãŒã·ã§ã³ããšãã®ãå©ããã2022幎6æã«å®äºäºå®ã®ãã®ç ç©¶ã§ã¯ããã³ã³ãã¥ãŒã¿ãå¶åŸ¡ããããã«è³ãããçŽæ¥åŸãããç¥çµä¿¡å·ãèšé²ã»åŸ©å·åã§ãããã©ãããæž¬å®ããäºå®ã§ãã
å¥ã®äŒç€ŸãSynchronã¯åãé åã§æŽ»åããŠãããFDAã®æ¿èªãåŸãŠããŸããã©ãããããµã«ã®é è骚ã«å¯ŸããŠåã蟌ãŸãã2ã€ã®ããããã1,024åã®é»æ¥µãæã€äŒéè£ çœ®ãéããŠãµã«ããè³ä¿¡å·ãéãããã®ä¿¡å·ããã³ãŒãããŠæ ¡æ£ãããµã«ãäœããããããäºæž¬ããããã®ãã®ã§ãããããã
Nia Therapeutics (Cortera Neurotechnologies)Â ãšææºããŠãããã³ã·ã«ããã¢å€§åŠã®ç¥çµç§åŠè ã¯ããä»ã®ç¥çµç§åŠé¢é£ã®åãçµã¿ãã®äžã§ã DARPA Restoring Active Memory (RAM) ãããžã§ã¯ãã®äžã§ãç¡ç·å¶åŸ¡ãããã¯ãããžãŒã«åºã¥ãé«åºŠãªç¥çµããã€ã¹ããäœçŸäººãã®äººéã®è¢«éšè ãã«ç§»æ€ããŠãå¹ åºãé åã®å®éšãè¡ã£ãŠããã®ã ããã§ãã
æåŸã«ãèŠåºã«ç¥çµåºæ¿è£ 眮ãåã蟌ãããšãå«ãæ·±éšè³åºæ¿ïŒDBSïŒãšåŒã°ãã䟵襲çãªå€ç§çææ³ã«ãåºäŒããŸããããã¹ãã³ã»ãµã€ãšã³ãã£ãã£ãã¯ç€ŸãFDAã®èªå¯ãååŸããæ¬æ æ§æ¯æŠãããŒãã³ãœã³ç ããžã¹ããã¢ã匷迫æ§é害ãªã©ã®æ²»çæ³ãšããŠãDBSã®å©çšãé²ãã§ããããã§ãã
ãã®ãããªäººéã®ã¢ã«ã¢ããã "ã¢ãŒãªãŒã¢ããã¿ãŒÂ "ãšåŒã¶ããšãã§ããã
ãããããããã®å®éšã¯åæã«åºã¥ãå«ççãªãã®ãªã®ã§ããããïŒãããŠããããã¯ãã¹ãŠFDAã®èªå¯ãåããŠããã®ã§ããããïŒ
éå¶å©ã®å ±åãã¥ãŒã¹ãµã€ãMuckRockã¯ãUPenn倧åŠã®ç¥çµç§åŠé¢é£ã®ç ç©¶ãããžã§ã¯ãã®ç¯å²å ã§ãéå«ççãŸãã¯éæ³ãªè¡çºãè¡ãããŠããå¯èœæ§ããããšçã£ãŠããŸããã³ã¡ã³ãããã£ãŒãããã¯ãæ±ããŠããäœã®åå¿ããªãã(ãŸãããImplantable Graphene Nanotechnology Investigational Device Exemption Approval Documentsããšé¡ãããªã³ã¯ãæ²èŒãããŠãããããã®ããŒãžã¯404ã§ãMuckRockããã¯é»è©±ãã¡ãŒã«ã§ã®åãåããã«ãå¿çããªã)ã

ãããã®å®éšã«ãã£ãŠéããããé«è§£å床ã®ç¥çµåŠçããŒã¿ã»ããã¯ããã°ãã°ãŠãããããã¬ã€ã³ã»ã³ã³ãã¥ãŒã¿ã»ã€ã³ã¿ãŒãã§ã€ã¹ïŒBCIïŒç ç©¶ã®åç®ã§ãããŸããŸãªæ©é¢ã®ç ç©¶è ã«ç§çã«é åžãããŠããã"ãšã
éå¶å©ã®æè·å£äœ
Physicians Committee For Responsible Medicine (PCRM)ã«ããNeuralinkã®åé€ãšæ®èè¡çºã®æŽé²ã«ç¶ããŠã人éãåä¹ãåºãŠãåæãªãã«è³ãããããããšäž»åŒµããŠããããããã®äººã ããã¯ã¬ã€ãžãŒããšäžè¹Žããã®ã¯ç°¡åã ããäžèšã®ãããªç ç©¶åªåãç¥ã£ãŠããã ãã«ãä¿¡ããã®ã¯é£ãããïŒã³ããã³ã³ãå¥åãã³ãããã¯ãšãã®éºäŒåæ²»çãžã£ãã¯ãæ°äžçç§©åºã®äžã§ãæã ã¯å®éšçšããºããšèŠãªãããŠããããšãæã ã«ç€ºããã®ã§ããã
PCRMãå人ã«ãã£ãŠå ±åããããã¹ãŠã®äºä»¶ãããã¥ãŒã©ãªã³ã¯ã«é¢ä¿ããŠããããã§ã¯ãããŸããããŸãããã®ãããªè¢«å®³ãåãããšããã人ãã¡ã®å€ãã¯ããã®èåŸã«ããäŒæ¥ãå£äœãå¿ ãããç¥ã£ãŠããããã§ã¯ãããŸããã
ãç§ã¯ã€ã³ãã©ãŒã ãã»ã³ã³ã»ã³ãã®ãªã人äœå®éšã®ç ç²è ã§ããããšAndy Pearsonã¯PCRMã«æžããŸãããããã®ãããªäººéã«å¯Ÿããç¯çœªã¯ãç±³åœãNIHã®ãããªé£éŠæ©é¢ãå·æ©é¢ããããŠå šç±³ã®ããã倧åŠãéããŠè¡ã£ãŠããã®ã§ãããã®ãããªäººé¡ã«å¯Ÿããç¯çœªã䞻匵ããŠããã®ã¯ãç§äžäººã§ããã¯ãããããŸãããã
ãã€ã³ãã£ã³ã°ã»ã¶ã»ãã€ã³ã èªç¥çèªç±ãšãã¥ãŒããã¯ãããžãŒÂ "é©åœ"

"匷å¶çã«å¿ãèªãŸããããšãããæ³çã«ä¿è·ãããããšã¯ãªã"
ãŠãŽã¡ã«ã»ãã¢ã»ãã©ãªãªã©ã®ãã©ã³ã¹ãã¥ãŒããã¹ãïŒã«ã·ãã§ãªã¢ã³ãšãªãŒãããç§ãã¡ã¯ä»ãããããã³ã°ã§ããåç©ãã§ãããèªç±æå¿ã®æä»£ã¯ãçµãã£ãããšèªãã®ã«ã¯çç±ããããŸãããã¥ãŒãã»ãã¯ãã®æªæ¥ã¯é²è¡äžã§ãããããã¯ç§ãã¡ã®äººæš©æ³ãåèªèãããæ°ãã人暩æ³ã®å¿ èŠæ§ãä¿ããŠããã®ã§ãã
ã©ãã ãã®äººã泚ç®ããŠããã®ã ãããã
ã©ã¡ãããšããã°ããµã€ããŒäŸµå ¥ããã€ãŠãªãã»ã©é«ãŸã£ãŠããä»ã人ã ã¯ã¡ã¿ããŒã¹ã«å¯ŸããŠèŠåœéãã®åã³ãæ±ããŠããããã©ã³ã¹ãã¥ãŒããã¹ããã¡ã¯ãã§ããéãã®ããšã远跡ããããªããã©ãåå¿ãããããããªããåå¿ããåã«ã§ãç¥ã£ãŠãããããšèããŠããã
GoogleãDisneyãCBSãFrito-Layãªã©ããã€ãã®å€åœç±äŒæ¥ã¯ãã§ã«ãæ¶è²»è ã®è¡åãçè§£ãã顧客ããæãŸããåå¿ãåŒãåºãããã«ããã¥ãŒãããŒã±ãã£ã³ã°ãã®ããã«è³ç»åã䜿çšããŠããŸãã
ãã¥ãŒããã¯ãããžãŒãåäžããäžè¬çã«ãªãã«ã€ããæè¡ããããã³ã°ããã第äžè ã誰ãã®å¿ããçèŽãã§ããããã«ãªãå±éºæ§ãããããšããNeuroscience Newsãã®2017幎ã®èšäºã«ã¯æžãããŠãããç¥çµå·¥åŠãè³ç»åããããŠåºç¯ãªãã¥ãŒããã¯ãããžãŒã®é²æ©ã«ãããå¿ã¯ãã¯ããã®ãããªé£æ»äžèœã®èŠå¡ã§ã¯ãªããªããããããªãã

å°æ¥ãã³ã³ã·ã¥ãŒããŒåããã¯ãããžãŒãå¶åŸ¡ããããã«äœ¿çšããããã¬ã€ã³ã»ã³ã³ãã¥ãŒã¿ãŒã»ã€ã³ã¿ãŒãã§ãŒã¹ã¯ã第äžè
ã«ãããã¯ãããžãŒãžã®æ»æã«ãã£ãŠããŠãŒã¶ãŒã身äœçã»ç²Ÿç¥çãã¡ãŒãžãåããå±éºæ§ãã¯ããã§ããã®ã§ãããŸãããããã®æ©åšããçæãããããŒã¿ã®ä¿è·ã«é¢ããå«ççã»æ³çãªæžå¿µãèæ
®ããå¿
èŠããããŸãã
"å¿ã¯å人ã®èªç±ãšèªå·±æ±ºå®ã®æåŸã®ç ŠãšèããããŠããŸãããç¥çµå·¥åŠãè³ç»åãç¥çµæè¡ã®é²æ©ã«ãããå¿ã®èªç±ãå±éºã«ãããããŸãã"ãšãããŒãŒã«å€§åŠãã€ãªã¡ãã£ã«ã«å«çç ç©¶æã®çé èè
ã§å士課çšã®åŠçã§ãããã«ãã§ãã€ãšã³ã«ã¯æžããŠããŸãã
ãã¥ãŒããµã€ãšã³ã¹ã»ãã¥ãŒã¹ã®èè
ãã¯ãè¿ãå°æ¥ãæŸåããã©ã€ãã·ãŒã®åªå€±ããä¿è·ããããã«ã4ã€ã®æ°ãã人暩æ³ãåºçŸããå¯èœæ§ã瀺åããŠããã"èªç¥çèªç±ã«å¯Ÿããæš©å©ã粟ç¥çãã©ã€ãã·ãŒã«å¯Ÿããæš©å©ã粟ç¥çå®å
šæ§ã«å¯Ÿããæš©å©ãå¿ççç¶ç¶æ§ã«å¯Ÿããæš©å©Â "ã§ãã
圌ãã®ææ¡ããæ³åŸã¯ã人ã
ã«Â "匷å¶çã§äŸµè¥²çãªãã¥ãŒããã¯ãããžãŒãæåŠããæš©å©ããã¥ãŒããã¯ãããžãŒã«ãã£ãŠåéãããããŒã¿ã®ãã©ã€ãã·ãŒãä¿è·ãããã¥ãŒããã¯ãããžãŒã®èª€çšã«ããæå·ããå¿ã®ç©ççããã³å¿ççåŽé¢ãä¿è·ããæš©å©Â "ãäžãããã®ã§ãã
å¿ççç¶ç¶ã®æš©å©ã«ãã£ãŠé²ãããšãã§ããæœåšçãªè
åšã«ã¯ãæ°ããåœ¢ã®æŽè³ãå«ãŸããŸããäŸãã°ãæªæã®ãããšãŒãžã§ã³ãããã¥ãŒãã¢ãžã¥ã¬ãŒã·ã§ã³ã䜿ã£ãŠãæªæã®ãããã€ã³ãã³ã³ãããŒã«ãè¡ãå¯èœæ§ãããã®ã§ãã
ãSFã¯ããã¯ãããžãŒã®æœåšçãªè
åšã«ã€ããŠå€ãã®ããšãæããŠããããæåãªç©èªã«ç»å Žããç¥çµæè¡ã¯ããã§ã«çŸå®ã®ãã®ãšãªã£ãŠãããã®ãããã°ãåŸã
ã«è¿ã¥ããŠãããã®ããããã¯è»äºçã»åæ¥çãªãããã¿ã€ããšããŠååšããŠãããã®ãããã®ã§ããç§ãã¡ã¯ããããã®ãã¯ãããžãŒãç§ãã¡ã®å人ã®èªç±ã«åãŒã圱é¿ã«å¯ŸåŠããæºåãããå¿
èŠããããŸãããšIencaã¯æžããŠããŸãã
ããªã¢ã ã»ããã€ã³
ã調æ»ãžã£ãŒããªã¹ãã§ãããHoneyColonyã®åµèšè å Œç·šéé·ããŸãããšãªãªããã»ãã€ãžããã¬ãŒã·ã§ã³ãæ åœããæ°ã ã®è³ãåè³ããããã¥ã¡ã³ã¿ãªãŒæ ç»ãVanishing of the Beesãã®ç£ç£ã§ããããGab:@ladybeeã§åœŒå¥³ããã©ããŒãããé»åã¡ãŒã«ïŒÂ maryam@honeycolony.com.
åèèšäº
ããªãŒããŒç ç©¶ã°ã«ãŒãã
ãªãŒããŒã°ã«ãŒãã¯ãããã¹ã±ãŒã«ã®ç§åŠæè¡ã«åºãçŠç¹ãåœãŠãŠãããæ°ããããææã®ç¬èªã®ç©ççç¹æ§ãå©çšããŠãçç©åŠãšå»åŠã®ç§åŠçå¢çãæŒãåºããŠããŸãã
âãããã€ãªã€ã³ã¿ãŒãã§ã€ã¹


âæ°çŽ æ



